1. American Diabetes Association: Clinical Evaluation of Drugs for the Treatment of Diabetes- Diabetes13 429, 1964.
2. Aum�ller W., Fauland E., Hagedorn A., Heerdt R., H�bner M., Muth K., Weber H., Weyer R., B�nder A., Pfaff W., Schmidt F. H., Stork H.: Acylaminoalkyl-benzolsulfonylsemicarbazide als blutzuckersenkende Substanzen - Arzneimittel-Forsch.19 1350, 1969.
3. B�nder A., Pfaff W., Schmidt F. H., Stork H., Schr�der H. G.: Zur Pharmakologie von HB 419, einem neuen, stark wirksamen oralen Antidiabetikum - Arzneimittel-Forsch.19 1963, 1969.
4. Benedict S. R.: The Detection and Estimation of Glucose in Urine - J. Amer. med. Ass.57 1193, 1911.
5. Fussg�nger R. D., Goberna R., Hinz M., Jaros P., Karsten C., Pfeiffer E. F., Raptis S.: Comparative Studies on the Dynamics of Insulin Secretion Following HB 419 and Tolbutamide of the Perfused Isolated Rat Pancreas and the Purifused Isolated Pieces and Islets of Rat Pancreas - Hormone metab. Res.1 (Suppl. 1), 34, 1969.